ProMetic Confirms Anti-Fibrotic Effect of Experimental IPF Therapy in Human Kidney Cells
Idiopathic Pulmonary Fibrosis, News
ProMetic Life Sciences Inc., a biopharmaceutical company with globally recognized expertise in bioseparations, plasma-derived therapeutics and small-molecule drug development, recently presented in London at the annual meeting of the European Renal Association ... Read more